GLP-1 Receptor Agonists Initiation and Risk of Acute Pancreatitis and Pancreatic Cancer: A Real-World Comparative Study.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- GLP-1 Receptor Agonists Initiation and Risk of Acute Pancreatitis and Pancreatic Cancer: A Real-World Comparative Study.
- Published In:
- American journal of medicine open, 14, 100114 (2025)
- Authors:
- Faour, Omar, Boktor, Moheb, Yau, Hanford, Kinaan, Mustafa, Mansi, Ishak A
- Database ID:
- RPEP-10903
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10903APA
Faour, Omar; Boktor, Moheb; Yau, Hanford; Kinaan, Mustafa; Mansi, Ishak A. (2025). GLP-1 Receptor Agonists Initiation and Risk of Acute Pancreatitis and Pancreatic Cancer: A Real-World Comparative Study.. American journal of medicine open, 14, 100114. https://doi.org/10.1016/j.ajmo.2025.100114
MLA
Faour, Omar, et al. "GLP-1 Receptor Agonists Initiation and Risk of Acute Pancreatitis and Pancreatic Cancer: A Real-World Comparative Study.." American journal of medicine open, 2025. https://doi.org/10.1016/j.ajmo.2025.100114
RethinkPeptides
RethinkPeptides Research Database. "GLP-1 Receptor Agonists Initiation and Risk of Acute Pancrea..." RPEP-10903. Retrieved from https://rethinkpeptides.com/research/faour-2025-glp1-receptor-agonists-initiation
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.